Fig. 2From: Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in childrenSurvival outcomes according to the cause of secondary HLH and treatment response. a The cause of secondary HLH. b Treatment response at 4 weeks. c Treatment response at 8 weeks. d Dynamic treatment responses at 8 weeksBack to article page